ADVOCACY THAT WORKED: THE CASE STUDY OF THE PINK PILL by RAYMOND RUPERT MD. MBA. RUPERT CASE MANAGEMENT INC.

Posted on in General

 

ADVOCACY THAT WORKED: THE CASE STUDY OF THE PINK PILL

RAYMOND RUPERT MD. MBA.  RUPERT CASE MANAGEMENT INC.

Men have the blue pill. Women will soon have the pink pill.  It is used to improve libido or sex drive.

The story of how the pink pill got government approval provides insights into how advocacy is handled by the pros.

 

Here’s some of the detail.

The feminists Susan Scanlan and Audrey Sheppard know their way around Washington. Cindy Whitehead is the head of the pharma company (Sprout Pharma) that was seeking approval for the pink pill.

These women together with a public relations company (Blue Engine Message & Media) were the central players in the campaign for approval of the pink pill.

The F.D.A. had previously rejected the application twice. The first rejection was in 2010. Ms Whitehead has seen video testimonials form women who had used the pill in clinical trials. It improved their lives and relationships. She and her husband who lead Sprout Pharma decided to try.

The buzz was that if the expert panel rejected the application, that it would be sexist.

Women felt that the F.D.A had decided that women’s sexual pleasure was not important.

However, this would not be enough unless passionate supporters were working to move impassive federal agencies.

A group named ” Even The Score” used social media to build momentum.  The effort by the advocacy organizations committed to providing a voice to women who suffer from a lack of sexual desire.

Experts wrote pieces for the Huffington Post. NBC news picked up the story during prime time news on at least two occasions.

Bus loads of supportive women were sent to Washington. The expert panel was confronted with a many passionate voices from women who had been harmed.

As a result of this pressure and the transparency in the press and on social media, the expert panel was encouraged to pick a compromise path.

On  June 4 2015, a panel of experts recommended approving the pink pill.

This is a very interesting scenario explaining how the pros advocate to win.

source: New York Times Sunday June 14 2015 ( section 1, pages 1 and 18)